THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

EntryPoint Capital, LLC's Holding History (CIK: 0001992519)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 34,575 Value ($000) $647 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 30,255 Value ($000) $442 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 27,904 Value ($000) $308 Avg Close $9.72 Range $7.90 - $11.82

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	34,575	$647	$16.59	$13.50 - $20.33
Q3 2025	30,255	$442	$12.64	$10.82 - $14.87
Q2 2025	27,904	$308	$9.72	$7.90 - $11.82